These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29241799)

  • 1. Vitiligo-like depigmentation in patients receiving programmed cell death-1 inhibitor reflects active vitiligo.
    Fukuda K; Harris JE
    J Am Acad Dermatol; 2018 Jan; 78(1):e15-e16. PubMed ID: 29241799
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitiligo-like lesions in patients receiving anti-programmed cell death-1 therapies are distinct from spontaneously occurring active vitiligo.
    Boniface K; Dutriaux C; Prey S; Taieb A; Seneschal J
    J Am Acad Dermatol; 2018 Jan; 78(1):e17-e18. PubMed ID: 29241800
    [No Abstract]   [Full Text] [Related]  

  • 3. Sparing phenomenon in salt and pepper pigmentation of systemic sclerosis: an unusual observation.
    Ghosh SK; Mondal S
    Clin Exp Dermatol; 2022 May; 47(5):967-969. PubMed ID: 34939220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confetti-like depigmentation: A potential sign of rapidly progressing vitiligo.
    Sosa JJ; Currimbhoy SD; Ukoha U; Sirignano S; O'Leary R; Vandergriff T; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2015 Aug; 73(2):272-5. PubMed ID: 26054430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy.
    Okamoto T; Irie RF; Fujii S; Huang SK; Nizze AJ; Morton DL; Hoon DS
    J Invest Dermatol; 1998 Dec; 111(6):1034-9. PubMed ID: 9856813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo-like depigmentation patterns in patients receiving immunotherapy for metastatic melanoma.
    Zottarelli F; Giorgione R; Gironi LC; Farinelli P; Sponghini AP; Rondonotti D; Savoia P
    Ital J Dermatol Venerol; 2021 Feb; 156(1):97-99. PubMed ID: 30350560
    [No Abstract]   [Full Text] [Related]  

  • 7. Nevus depigmentosus: the analysis of 37 cases.
    Sharquie KE; Al-Jaralla FA; Schwartz RA; Alhyali RM
    Ital J Dermatol Venerol; 2021 Feb; 156(1):62-67. PubMed ID: 33228333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis.
    Teulings HE; Limpens J; Jansen SN; Zwinderman AH; Reitsma JB; Spuls PI; Luiten RM
    J Clin Oncol; 2015 Mar; 33(7):773-81. PubMed ID: 25605840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism.
    Merimsky O; Shoenfeld Y; Yecheskel G; Chaitchik S; Azizi E; Fishman P
    Cancer Immunol Immunother; 1994 Jun; 38(6):411-6. PubMed ID: 8205563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo.
    Eby JM; Kang HK; Tully ST; Bindeman WE; Peiffer DS; Chatterjee S; Mehrotra S; Le Poole IC
    J Invest Dermatol; 2015 Jun; 135(6):1574-1580. PubMed ID: 25634358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo-Like Depigmentation Induced by Anti-Programmed Death 1 Antibody.
    Zhang LW; Fu LX; Wang WJ; Lu YH; Chen T
    Dermatitis; 2023; 34(1):66-67. PubMed ID: 36917500
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of the Q-switched 755-nm alexandrite laser to treat recalcitrant pigment after depigmentation therapy for vitiligo.
    Rao J; Fitzpatrick RE
    Dermatol Surg; 2004 Jul; 30(7):1043-5. PubMed ID: 15209798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depigmentation of the male genitalia.
    Gaffoor PM
    Cutis; 1984 Nov; 34(5):492-4. PubMed ID: 6499535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo-like lesions occurring in patients receiving anti-programmed cell death-1 therapies are clinically and biologically distinct from vitiligo.
    Larsabal M; Marti A; Jacquemin C; Rambert J; Thiolat D; Dousset L; Taieb A; Dutriaux C; Prey S; Boniface K; Seneschal J
    J Am Acad Dermatol; 2017 May; 76(5):863-870. PubMed ID: 28094061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological basis of melanoma-associated vitiligo-like depigmentation.
    González R; Torres-López E
    Actas Dermosifiliogr; 2014 Mar; 105(2):122-7. PubMed ID: 23146137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monobenzone, Superfade, vitiligo and confetti-like depigmentation.
    Catona A; Lanzer D
    Med J Aust; 1987 Mar; 146(6):320-1. PubMed ID: 3821640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociated depigmentation in vitiligo; significance and therapeutic implications.
    PEGUM JS
    Br J Dermatol; 1955 Oct; 67(10):348-50. PubMed ID: 13260554
    [No Abstract]   [Full Text] [Related]  

  • 18. HYPOMELANOSIS.
    FITZPATRICK TB
    South Med J; 1964 Sep; 57():995-1005. PubMed ID: 14179333
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitiligo-like manifestations of graft-versus-host disease in a pediatric population.
    Dai J; Hight RS; Grullon K; Xiao TL; Stein SL
    Pediatr Dermatol; 2023 Jan; 40(1):157-161. PubMed ID: 36063124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of residual perifollicular pigmentation in localized vitiligo--a reverse and novel application of digital epiluminescence dermoscopy.
    Chuh AA; Zawar V
    Comput Med Imaging Graph; 2004 Jun; 28(4):213-7. PubMed ID: 15121210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.